Thermo Fisher Expands Bangalore R&D Centre with ₹160 Crore, Fueling Innovation
Thermo Fisher Bangalore: The Global Icon Thermo Fisher Scientific, the largest US-based Life Science Company, has announced the investment of ₹160 crore to expand its Bangalore R&D facility. The newly expanded 37,000 sq. ft. facility, Center for Excellence, mainly focuses on advanced research in the field of antibody design, development, and manufacturing, and integrating leading-edge automation and analytical platforms to support immunoassays, protein analysis, and cell-based studies.
Pioneering Research and Job Creation
With the expansion of Bangalore’s facility to 37,000 sq. ft., equipped with advanced automation and an analytical platform, Thermo Fisher Scientific has taken a step forward by creating 100-plus new job opportunities in the coming years. The decision not only creates employment but also helps young researchers to explore different ends of the field.
Bangalore facility had been the core centre, contributing to global life science research and development for the past 18 years. The strategic hub has developed over 2000 high-quality recombinant antibodies that have contributed to advancements in infectious diseases, antiviral studies, and cancer biology. Continuing, the validation program has tested over 25,000 antibodies, while the manufacturing division has produced 2000 primary and secondary antibodies , ensuring quality and reproducibility for global researchers.
Sanjeev Kumar Gupta, CEO, Karnataka Digital Economy Mission (KDEM) inaugurated Bangalore’s R&D Centre, in the presence of dignitaries from KEONICS and the Karnataka Innovation & Technology Society (KITS).
Thermo Fisher, the American life sciences research company’s initiative, catalyzes Karnataka’s commitment to science and innovation.
“By investing in talent and capabilities here, we will accelerate scientific progress and better serve customers in India and globally,” Gianluca Pettiti, Executive Vice-President and Sector President of Life Sciences, Diagnostics & Applied Sector at Thermo Fisher, added.
As India continues to strengthen its life sciences domain, investments like these can have a multiplier effect, encouraging native talent, boosting biotech manufacturing, and establishing an R&D hub. For Thermo Fisher, the expansion in Bangalore will deepen its capabilities and support its global customers via the India center.
